The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 09, 2021
Filed:
Sep. 26, 2017
Applicant:
Qingdao Primedicine Pharmaceutical Company, Ltd., Qingdao Shandong, CN;
Inventors:
Yu Tian Wang, Vancouver, CA;
Peter Axerio-Cilies, Lions Bay, CA;
Assignee:
Qingdao Primedicine Pharmaceutical Company, Ltd., Qingdao Shandong, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/165 (2006.01); A61K 31/166 (2006.01); A61K 31/4406 (2006.01); A61K 31/4409 (2006.01); A61K 31/655 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/166 (2013.01); A61K 31/165 (2013.01); A61K 31/4406 (2013.01); A61K 31/4409 (2013.01); A61K 31/655 (2013.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 25/30 (2018.01);
Abstract
This invention relates to therapeutic compounds and compositions, and methods for their use in the prevention or treatment of neurological disorders. In particular, the invention relates to N-methyl-D-aspartate receptor (NMDAR) allosteric modulators and methods for their use in the prevention or treatment of disorders or conditions caused by or related to NMDAR dysfunctions. The invention also relates to a method for identifying NMDAR allosteric modulators.